Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
UK-based CDMO, Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina.
read more
Wednesday, April 03, 2019
Chr. Hansen Holding A/S and Lonza have signed an agreement to establish a 50/50 joint venture to develop the live biotherapeutic products (LBPs) industry.
read more
Wednesday, April 03, 2019
Pii and AST have announced their partnership on the new GENiSYS® R filling machine for syringes, cartridges and vials.
read more
Wednesday, April 03, 2019
Novartis has entered into an agreement and plan of merger with AveXis to acquire the US-based clinical stage gene therapy company for $218 per share or a total of $8.7 billion in cash.
read more
West Pharmaceutical Services has expanded its presence in the Asia Pacific region with a new sales office in Korea—West Pharmaceutical Services Korea Ltd.
read more
UK-based CDMO, Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US.
read more
Masy BioServices announced it has acquired Metrology Laboratories, Inc. (MLI) a calibration services provider located in Rockaway, NJ.
read more
We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.
read more
LakePharma has announced the launch of GMP manufacturing of recombinant proteins and antibodies with CHO-GSN™ and TunaCHO™ platforms at its Hayward, California facility.
read more
AveXis has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Colorado, further expanding its capacity as it prepares to launch Zolgensma®.
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more
Wednesday, April 10, 2019
ReNeuron has signed a license agreement with Shanghai Fosun Pharmaceutical for the development, manufacture and commercialization of ReNeuron's CTX and hRPC cell therapy programs in China.
read more
Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
read more
Cambrex announced that it has completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.
read more
Fujifilm Diosynth Biotechnologies has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
read more